A Study of Arformoterol Tartrate Inhalation Solution and Tiotropium Bromide on Re-hospitalization in Chronic Obstructive Pulmonary Disease (COPD) Subjects
Public ClinicalTrials.gov record NCT02275481. Field values are reproduced from the official study page; the official ClinicalTrials.gov record remains the source of truth for eligibility, enrollment, and contact information.
Data is sourced from official ClinicalTrials.gov public API records. Always review the official ClinicalTrials.gov record for the latest information.
Official title
A Comparative Effectiveness and Safety Study of Arformoterol Tartrate Inhalation Solution and Tiotropium Bromide on Re-hospitalization in Chronic Obstructive Pulmonary Disease (COPD) Subjects
Brief summary
Reproduced verbatim from the official ClinicalTrials.gov record. Not medical advice.
This is a randomized, open-label, parallel group, multicenter, outpatient study in COPD subjects who are discharged from the hospital due to a COPD exacerbation. Subjects who meet the eligibility criteria will be randomized to 1 of 2 treatments: arformoterol tartrate inhalation solution (BROVANA) 15 mcg twice daily (BID) or tiotropium bromide (SPIRIVA) 18 mcg once daily (QD), each given for 90 days.
Study identification
- NCT ID
- NCT02275481
- Recruitment status
- Terminated
- Study type
- Interventional
- Phase
- Phase 4
- Enrollment
- 66 participants
Conditions and interventions
Conditions
Eligibility (public fields only)
- Age range
- 55 Years and older
- Sex
- All
- Healthy volunteers
- Healthy volunteers not accepted
This page does not interpret eligibility. Detailed inclusion and exclusion criteria are on the official ClinicalTrials.gov record.
Study timeline
- Start date
- Nov 2014 (Actual)
- Primary completion
- Sep 14, 2016 (Actual)
- Completion
- Sep 14, 2016 (Actual)
- Last update posted
- Jun 27, 2018
2014 – 2016
United States locations
- U.S. sites
- 28
- U.S. states
- 17
- U.S. cities
- 27
| Facility | City | State | ZIP | Site status |
|---|---|---|---|---|
| Birmingham VA Medical Center | Birmingham | Alabama | 35233 | — |
| Clinical Trial Connection | Flagstaff | Arizona | 86001 | — |
| Waterbury Pulmonary Associates LLC | Waterbury | Connecticut | 06708 | — |
| George Washington University Medical Faculty Associates | Washington D.C. | District of Columbia | 20037 | — |
| Southeastern Intergrted Medical, PL d/b/a Florida Medical Research | Gainesville | Florida | 32607 | — |
| Miami VA Medical Center | Miami | Florida | 33125 | — |
| Gwinnett Biomedical Research | Lawrenceville | Georgia | 30046 | — |
| University of Maryland Medical Center | Baltimore | Maryland | 21201 | — |
| Brigham and Women's Hospital | Boston | Massachusetts | 02115 | — |
| University of Nebraska Medical Center | Omaha | Nebraska | 68198 | — |
| VA Western New York Healthcare System | Buffalo | New York | 14215 | — |
| Clinical Research of Gastonia | Gastonia | North Carolina | 28054 | — |
| Gastonia Phannaceutical Research | Gastonia | North Carolina | 28054 | — |
| Clinical Research of Lake Norman | Huntersville | North Carolina | 28078 | — |
| PMG Research of Wilmington | Wilmington | North Carolina | 28401 | — |
| Southeastern Research Center | Winston-Salem | North Carolina | 27103 | — |
| Cincinnati Veterans Affairs Medical Center | Cincinnati | Ohio | 45220 | — |
| Remington-Davis, Inc. | Columbus | Ohio | 43215 | — |
| Consolidated Clinical Trials, Inc. | Monroeville | Pennsylvania | 15146 | — |
| Temple University Hospital, Temple Lung Center | Philadelphia | Pennsylvania | 19140 | — |
| Upstate Pharmaceutical Research | Greenville | South Carolina | 29615 | — |
| Clinical Research of Rock Hill | Rock Hill | South Carolina | 29732 | — |
| S. Carolina Pharmaceutical Research | Spartanburg | South Carolina | 29303 | — |
| Mid State Pulmonary | Nashville | Tennessee | 37203 | — |
| Family Medicine Rural Health Clinic, PA, DBA FMC Science | Lampasas | Texas | 76550 | — |
| Metroplex Pulmonary and Sleep Center | McKinney | Texas | 75069 | — |
| Alamo Clinical Research Associates | San Antonio | Texas | 78212 | — |
| Swedish Medical Center | Seattle | Washington | 98122 | — |
Site contact phone numbers, emails, and investigator names are intentionally not displayed here. Open the official ClinicalTrials.gov record for site contact information.
About this trial record page
- What this page shows
- Public field values for ClinicalTrials.gov record NCT02275481, including study identification, conditions, interventions, eligibility (age, sex, healthy volunteer), timeline, and U.S. site list.
- What this page does not do
- No medical advice, eligibility judgments, treatment recommendations, study quality scoring, or AI-generated medical summaries. No site contact phone numbers, emails, or investigator names.
- Where the data comes from
- Sourced from the official ClinicalTrials.gov public API. The official record is the source of truth.
- Last refresh
- Last update posted Jun 27, 2018 · Synced Oct 19, 2026
Related: full search, browse by condition, browse by drug or therapy, browse by sponsor, browse by U.S. city.
Open the official record
The complete public registry record, listed eligibility criteria, and available contact information for NCT02275481 live on ClinicalTrials.gov.